第一单位：
School of Health & Medical Sciences, City St George's, University of London, London, United Kingdom.
作者：
Kazim,Ogmen [1]
;
Sara E,Dobbins [1]
;
Rose Yinghan,Behncke [2]
;
Ines,Martinez-Corral [3]
;
Ryan Cs,Brown [4]
;
Michelle,Meier [5]
;
Sascha,Ulferts [6]
;
Nils Rouven,Hansmeier [7]
;
Ege,Sackey [8]
;
Ahlam,Alqahtani [9]
;
Christina,Karapouliou [1]
;
Dionysios,Grigoriadis [1]
;
Juan C,Del Rey Jimenez [10]
;
Michael,Oberlin [11]
;
Denise,Williams [12]
;
Arzu,Ekici [13]
;
Kadri,Karaer [14]
;
Steve,Jeffery [1]
;
Peter,Mortimer [15]
;
Kristiana,Gordon [15]
;
Kazuhide S,Okuda [16]
;
Benjamin M,Hogan [16]
;
Taija,Mäkinen [17]
;
René,Hägerling [18]
;
Sahar,Mansour [8]
;
Silvia,Martin-Almedina [1]
;
Pia,Ostergaard [1]
作者单位：
School of Health & Medical Sciences, City St George's, University of London, London, United Kingdom.
[1]
Research Group Lymphovascular Medicine and Translational 3D-Histopathology, Institute of Medical and Human Genetics, Charité - Universitätsmedizin Berlin, Germany.;Berlin Institute of Health at Charité - Universitätsmedizin Berlin, BIH Center for Regenerative Therapies, Berlin, Germany.
[2]
Department of Immunology, Genetics and Pathology, Uppsala University, Sweden.
[3]
Organogenesis and Cancer Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
[4]
Organogenesis and Cancer Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.;Sir Peter MacCallum Department of Oncology and Department of Anatomy and Physiology, University of Melbourne, Victoria, Australia.;Bioinformatics Core Facility, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
[5]
Research Group Lymphovascular Medicine and Translational 3D-Histopathology, Institute of Medical and Human Genetics, Charité - Universitätsmedizin Berlin, Germany.
[6]
Research Group Lymphovascular Medicine and Translational 3D-Histopathology, Institute of Medical and Human Genetics, Charité - Universitätsmedizin Berlin, Germany.;Research Group Development and Disease, Max Planck Institute for Molecular Genetics, Berlin, Germany.
[7]
School of Health & Medical Sciences, City St George's, University of London, London, United Kingdom.;South West Thames Centre for Genomics, St George's University Hospitals NHS Foundation Trust, London, United Kingdom.
[8]
Bioscience Institute, Wolfson Childhood Cancer Research Centre, Brewery Lane, Newcastle University, Newcastle upon Tyne, United Kingdom.
[9]
South West Thames Centre for Genomics, St George's University Hospitals NHS Foundation Trust, London, United Kingdom.
[10]
Földiklinik GmbH & Co. KG, European Center for Lymphology Black Forest, Hinterzarten, Germany.
[11]
The National Congenital Anomaly and Rare Diseases Registration Services (NCARDRS) NHS England, Birmingham Government Hub, Birmingham, United Kingdom.
[12]
University of Health Sciences, Bursa Yüksek Īhtisas Training and Research Hospital, Department of Pediatric Neurology, Bursa, Turkey.
[13]
Department of Medical Genetics, Pamukkale University Faculty of Medicine, Denizli, Turkey.
[14]
School of Health & Medical Sciences, City St George's, University of London, London, United Kingdom.;Dermatology & Lymphovascular Medicine, St George's University Hospitals NHS Foundation Trust, London, United Kingdom.
[15]
Organogenesis and Cancer Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.;Sir Peter MacCallum Department of Oncology and Department of Anatomy and Physiology, University of Melbourne, Victoria, Australia.
[16]
Department of Immunology, Genetics and Pathology, Uppsala University, Sweden.;Translational Cancer Medicine Program and Department of Biochemistry and Developmental Biology, University of Helsinki, Helsinki, Finland.;Wihuri Research Institute, Helsinki, Finland.
[17]
Research Group Lymphovascular Medicine and Translational 3D-Histopathology, Institute of Medical and Human Genetics, Charité - Universitätsmedizin Berlin, Germany.;Berlin Institute of Health at Charité - Universitätsmedizin Berlin, BIH Center for Regenerative Therapies, Berlin, Germany.;Research Group Development and Disease, Max Planck Institute for Molecular Genetics, Berlin, Germany.
[18]
DOI
10.1172/jci.insight.177656
PMID
41427784
发布时间
2026-02-14
换一批
